← Back
$AXSM All transactions

Axsome Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$1.2M

Shares

10,000

Price

$116

Filed

Sep 22

Insider

Name

Jacobson Mark L.

Title

Chief Operating Officer

CIK

0001805812

Roles

Officer

Transaction Details

Transaction Date

2025-09-22

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options. | Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed. | Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $115.11 and $116.55.

Filing Info

Accession No.

0001193125-25-211788

Form Type

4

Issuer CIK

0001579428

Jacobson Mark L.'s History

Date Ticker Type Value
2026-04-21 AXSM A $0
2026-02-26 AXSM M $101K
2026-02-26 AXSM $5.7M
2026-02-26 AXSM M $0
2026-02-26 AXSM A $0
2025-09-22 AXSM M $28K
2025-09-22 AXSM $1.2M
2025-09-22 AXSM M $0
2025-09-16 AXSM $672K
2025-09-16 AXSM M $124K

Other Insiders at AXSM (90d)

Insider Bought Sold Last
TABUTEAU HERRIOT
Chief Executive Officer
$6.0M 2026-04-21
Coleman Mark $4.0M 2026-02-26
Pizzie Nick
Chief Financial Officer
2026-04-21
Jacobson Mark L.
Chief Operating Officer
$5.7M 2026-04-21
Murdock Hunter R.
General Counsel
2026-04-21
Maizel Ari
Chief Commercial Officer
$1.4M 2026-04-22